Program Description:
The Agilent Biodesign Program (ABP) was created on Jan 1, 2020 to stimulate and fund academic research at Berkeley that is of mutual interest and highest relevance to Agilent. Agilent, a global leader in life science, diagnostics and analytical laboratory technologies, provides trusted answers that help our customers solve their most ambitious scientific challenges, increase laboratory performance, and advance quality of life. ABP continues a strong tradition of partnership between Berkeley and Agilent, succeeding a 10-year collaboration via the Synthetic Biology Institute (SBI). ABP will expand on previous topics of interest to include all analytical technologies that serve Agilent customers and end markets.
Please reach out to the ABP leadership team to learn how you can get involved.
